![Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/65e952ae-e757-4807-ad51-b3e27f846e35/adtp202100035-fig-0001-m.jpg)
Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress - Pires - 2021 - Advanced Therapeutics - Wiley Online Library
![MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aan4470/asset/33b79a75-5694-4a27-931b-20f56bccb6fb/assets/graphic/aan4470-f1.jpeg)
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine
![Frontiers | Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification Frontiers | Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification](https://www.frontiersin.org/files/Articles/1070338/fcell-10-1070338-HTML/image_m/fcell-10-1070338-t001.jpg)
Frontiers | Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification
![Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020 Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020](https://journals.sagepub.com/cms/10.1177/1078155219895079/asset/images/large/10.1177_1078155219895079-fig1.jpeg)
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020
![Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines](https://www.mdpi.com/cancers/cancers-14-00041/article_deploy/html/images/cancers-14-00041-g008.png)
Cancers | Free Full-Text | The Effect of Direct and Indirect EZH2 Inhibition in Rhabdomyosarcoma Cell Lines
![BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27176-w/MediaObjects/41467_2021_27176_Fig1_HTML.png)
BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications
![Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches - Mahadik - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches - Mahadik - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/a517180d-7c47-432c-ac74-ba56a4e5877c/wnan1755-toc-0001-m.jpg)
Targeting steroid hormone receptors for anti‐cancer therapy—A review on small molecules and nanotherapeutic approaches - Mahadik - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library
![Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00136/asset/images/medium/jm1c00136_0002.gif)
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry
![Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies: Trends in Cell Biology Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies: Trends in Cell Biology](https://www.cell.com/cms/attachment/40045831-7443-4851-ac99-229f25db36f2/gr1.jpg)
Ectopic biomolecular phase transitions: fusion proteins in cancer pathologies: Trends in Cell Biology
![JCM | Free Full-Text | Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia JCM | Free Full-Text | Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia](https://pub.mdpi-res.com/jcm/jcm-10-01926/article_deploy/html/images/jcm-10-01926-g001.png?1619769793)
JCM | Free Full-Text | Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
![PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma](https://i1.rgstatic.net/publication/356563513_BAF_complexes_drive_proliferation_and_block_myogenic_differentiation_in_fusion-positive_rhabdomyosarcoma/links/61a1c0777323543e210c1085/largepreview.png)
PDF) BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma
![Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development Applying a clinical lens to animal models of CAR-T cell therapies: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/dede4b9f-f2af-4915-9cc7-a4c5d69f6391/fx1_lrg.jpg)